TD Waterhouse Canada’s Perspective Therapeutics CATX Stock Holding History

TD Waterhouse Canada’s Portfolio CATX Stock Details CATX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$690	Hold	200	–	–	﹤0.01%	2223
2026 Q1	$876	Hold	200	–	–	﹤0.01%	2109
2025 Q4	$548	Hold	200	–	–	﹤0.01%	1906
2025 Q3	$686	Hold	200	–	–	﹤0.01%	1919
2025 Q2	$654	Hold	200	–	–	﹤0.01%	1839
2025 Q1	$386	Hold	200	–	–	﹤0.01%	1811
2024 Q4	$636	Hold	200	–	–	﹤0.01%	1809
2024 Q3	$2.53K	Hold	200	–	–	﹤0.01%	1605
2024 Q2	$2.24K	Hold	200	–	–	﹤0.01%	1630
2024 Q1	$2.9K	Hold	200	–	–	﹤0.01%	1622
2023 Q4	$1.14K	Hold	200	–	–	﹤0.01%	1546
2023 Q3	$528	Hold	200	–	–	﹤0.01%	1590
2023 Q2	$1.33K	Hold	200	–	–	﹤0.01%	1583
2023 Q1	$1.35K	Hold	200	–	–	﹤0.01%	1563
2022 Q4	$488	Hold	200	–	–	﹤0.01%	1616
2022 Q3	$540	Hold	200	–	–	﹤0.01%	1622
2022 Q2	$584	Hold	200	–	–	﹤0.01%	1658
2022 Q1	$730	Hold	200	–	–	﹤0.01%	1694
2021 Q4	$802	Buy	+200	New	+$1.07K	﹤0.01%	1665

Other funds holding CATX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

SSC

Spruce Street Capital New York $510M AUM

TD Waterhouse Canada's CATX Position: Q2 2026 in Review

TD Waterhouse Canada held its Perspective Therapeutics (CATX) position steady in Q2 2026 at 200 shares worth $690. The position accounts for ﹤0.01% of the portfolio, ranked #2223.

TD Waterhouse Canada first reported a position in CATX in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.9K in Q1 2024. 131 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

TD Waterhouse Canada held 200 shares of Perspective Therapeutics worth $690 as of Q2 2026.
TD Waterhouse Canada left its Perspective Therapeutics share count unchanged in Q2 2026.
Perspective Therapeutics made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #2223 holding.
TD Waterhouse Canada first reported a position in Perspective Therapeutics in Q4 2021 and has held it in 19 quarters since.
TD Waterhouse Canada's Perspective Therapeutics position peaked at $2.9K in Q1 2024.
131 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.